| Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study |
|---|---|---|---|---|---|---|---|
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 88 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 140 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 3 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 188 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 6 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 213 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 226 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 345 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 8 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 407 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 527 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 634 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 6 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 666 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 769 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 3 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 770 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 775 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 6 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 807 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 809 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 3 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 825 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 865 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 951 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 7 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 1218 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 1247 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 3 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 1280 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 8 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 1348 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 3 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 1431 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 6 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 18783 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 8 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 21856 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 8 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 22793 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 6 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 27581 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 35677 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 8 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 38877 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 39790 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 41481 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 41669 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 43867 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 43969 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 44403 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 8 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 44468 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 44828 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 45633 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 46487 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 46531 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 55442 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 3 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 59218 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 69214 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 75477 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 76717 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 77346 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 78446 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 84899 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 6 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 86750 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 6 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 91296 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 3 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 93327 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 7 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 101376 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 134885 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 6 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 167768 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 171259 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 206953 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 6 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 212470 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 3 |
| GC POSITIVE ION MODE | 3-(3-hydroxyphenyl)propionic acid | 240661 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 3 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|